Impact of Integrating an App into the Management of Patients with Migraine in the Primary Care Setting
AHSAM 2020 - Poster session
Published on July 30, 2020
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
- This study examined whether integration of patient-reported migraine data from a commercially available smartphone app (MigrnX® by SensorRx) would impact prescribing of preventive migraine medications.
- The intervention of integrating an app with the EHR led to a small but statistically significant increase in prescribing of preventive migraine medications, which was driven primarily by more prescribing of anticonvulsants.
- Prescribing increased with increasing underlying MIDAS scores, and provider “click” behavior indicates that any influence was not driven by direct patient-provider communication.
Gerhardt M. Pohl, PhD
Research Advisor, Global Patient Outcomes and Real World Evidence
Eli Lilly and Company
Gerhardt Pohl, PhD, is a Research Advisor in Global Patient Outcomes and Real World Evidence at Eli Lilly and Company. Pohl has over 30 years of experience in the pharmaceutical industry. Formally trained as both a chemist and mathematician with degrees from Northwestern University and the University of Illinois at Chicago, Pohl has spent the past decade exploring issues of cost effectiveness and process improvement in healthcare.